Finance

Lists
Why is TNYA down 25,05%?
Dive Deeper
TNYA:NASDAQ
Tenaya Therapeutics Inc
US$0,39
-25,05%
(-0,13) 1D
US$0,39
+0,38% (+0,0015)
Pre-market
Closed: 14 ຕ.ລ., 16 ໂມງ 0 ນາທີ 00 ວິນາທີ GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for TNYA...
Open
US$0,50
High
US$0,51
Low
US$0,36
Mkt. cap
87,73 ລ້ານ
Avg. vol.
2,73 ລ້ານ
Volume
49,17 ພັນ
52-wk high
US$2,04
52-wk low
US$0,36
EPS
US$-0,53
Beta
2,87
Shares outstanding
224,23 ລ້ານ
No. of employees
70
Open
US$0,50
High
US$0,51
Low
US$0,36
Mkt. cap
87,73 ລ້ານ
Avg. vol.
2,73 ລ້ານ
Volume
49,17 ພັນ
52-wk high
US$2,04
52-wk low
US$0,36
EPS
US$-0,53
Beta
2,87
Shares outstanding
224,23 ລ້ານ
No. of employees
70
News stories
From web sources and news partners
Benzinga
Benzinga
·
19 ຊົ່ວໂມງກ່ອນ
12 Health Care Stocks Moving In Wednesday's Intraday Session
Quiver Quantitative
Quiver Quantitative
·
21 ຊົ່ວໂມງກ່ອນ
$TNYA stock is down 24% today. Here's what we see in our data.
Investing.com Nigeria
Investing.com Nigeria
·
1 ມື້ກ່ອນ
Form PRE 14A Tenaya Therapeutics Inc For: 14 October By Investing.com
About Tenaya Therapeutics Inc
CEO-
Employees70
Founded2016
HeadquartersSouth San Francisco, ແຄລິຟໍເນຍ, ສະຫະລັດ
SectorBiotechnology
Analyst ratings
Based on 5 analysts giving stock ratings to TNYA in the past 3 months
Strong buy
Buy
5
Hold
0
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for TNYA in the last 3 months.
Highest
Current US$0,39
US$40,00 (+10.143,28%)
Average
US$13,00 (+3.229,07%)
Lowest
US$3,00 (+668,25%)
Analyst
Recommendation
Action
Price target
Projected
Date
Joseph Pantginis
H.C. Wainwright
Buy
Maintained
US$3,00
+668,2%
10/05/2026
Whitney Ijem
Canaccord Genuity
Buy
Maintained
US$5,00
+1.180,4%
08/06/2026
Cory Jubinville, PhD
LifeSci Capital
Buy
Maintained
US$4,00
+924,3%
08/06/2026
Yasmeen Rahimi
Piper Sandler
Buy
Maintained
US$40,00
+10.143,3%
08/06/2026
Sami Corwin
William Blair
Buy
Maintained
-
-
08/06/2026
Andy Hsieh
William Blair
Buy
Maintained
-
-
07/29/2026
Michael Ulz
Morgan Stanley
Buy
Reiterated
US$2,00
+412,2%
06/03/2026
Geulah Livshits
Chardan Capital
Buy
Reiterated
US$8,00
+1.948,7%
05/15/2026
Last report
5 ສ.ຫ. 2026
Fiscal period
Q2 2026
US$-0,09 / US$-0,07
-35,90%miss
Revenue / Est. (USD)
1,11 ລ້ານ / 10,00 ລ້ານ
-88,90%miss
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
ກ.ຍ. 2025
ທ.ວ. 2025
ມ.ນ. 2026
ມິ.ຖ. 2026
Revenue
-
-
225,00 ພັນ
1,11 ລ້ານ
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
15,36 ລ້ານ
14,80 ລ້ານ
14,84 ລ້ານ
16,60 ລ້ານ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5,57 ລ້ານ
5,98 ລ້ານ
5,45 ລ້ານ
5,41 ລ້ານ
Operating expense
20,94 ລ້ານ
20,78 ລ້ານ
20,29 ລ້ານ
22,01 ລ້ານ
Total operating expenses
20,94 ລ້ານ
20,78 ລ້ານ
20,29 ລ້ານ
22,01 ລ້ານ
Operating income
-20,94 ລ້ານ
-20,78 ລ້ານ
-20,06 ລ້ານ
-20,90 ລ້ານ
Other non operating income
3,00 ພັນ
25,00 ພັນ
-
-1,37 ລ້ານ
EBT including unusual items
-20,28 ລ້ານ
-20,18 ລ້ານ
-19,27 ລ້ານ
-43,39 ລ້ານ
EBT excluding unusual items
-20,28 ລ້ານ
-20,18 ລ້ານ
-19,27 ລ້ານ
-21,57 ລ້ານ
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-20,28 ລ້ານ
-20,18 ລ້ານ
-19,27 ລ້ານ
-43,39 ລ້ານ
Net profit margin
-
-
-8.565,33%
-3.909,28%
Earnings per share
-0,12
-0,12
-0,09
-0,09
Interest and investment income
658,00 ພັນ
575,00 ພັນ
793,00 ພັນ
697,00 ພັນ
Interest expense
-
-
-
-
Net interest expenses
658,00 ພັນ
575,00 ພັນ
793,00 ພັນ
697,00 ພັນ
Depreciation and amortization charges
-
-
-
-
EBITDA
-19,07 ລ້ານ
-18,95 ລ້ານ
-18,30 ລ້ານ
-19,20 ລ້ານ
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
ແອັບຂອງ Google